Table 6

Prevalence ratio (PR) of willingness to participate in HIV cure research procedures based on gender, employment status, education and the belief that an HIV cure is available

Gender (TGW/ W vs travestis)Employment status (employed vs unemployed)Education (at least high school vs until incomplete high school)Believe that HIV cure is available (Yes vs No)
PR95% CIP valuePR95% CIP valuePR95% CIP valuePR95% CIP value
New, untested treatments1.170.91 to 1.490.120.750.55 to 1.030.011.050.88 to 1.260.571.070.91 to 1.270.45
Early safety studies1.241.00 to 1.520.010.940.78 to 1.120.391.030.89 to 1.190.721.040.89 to 1.190.66
Focus group discussions1.030.90 to 1.180.621.121.00 to 1.250.091.161.00 to 1.340.020.890.74 to 1.050.09
Tissue biopsies0.820.70 to 0.960.050.970.77 to 1.220.791.030.84 to 1.260.760.890.71 to 1.120.25
Therapeutic vaccines0.990.84 to 1.160.890.860.72 to 1.030.060.990.86 to 1.150.931.010.85 to 1.200.93
Autologous transplants0.920.83 to 1.030.300.980.84 to 1.140.790.920.82 to 1.030.280.980.83 to 1.160.80
Efficacy studies1.080.88 to 1.320.420.910.72 to 1.140.321.030.87 to 1.230.690.880.72 to 1.070.16
Blood draws0.950.89 to 1.020.260.980.88 to 1.080.590.950.89 to 1.020.270.970.88 to 1.080.63
Online surveys1.040.88 to 1.220.611.000.85 to 1.180.981.120.94 to 1.340.150.980.84 to 1.150.80
Leukapheresis/apheresis1.000.81 to 1.250.971.040.86 to 1.260.691.080.88 to 1.320.450.870.70 to 1.080.18
Unique proteins or T cells1.050.79 to 1.410.690.920.68 to 1.260.590.880.69 to 1.110.310.990.76 to 1.300.96
Broadly neutralising antibodies1.140.83 to 1.550.380.860.63 to 1.180.290.920.71 to 1.210.571.000.74 to 1.360.98
Treatment interruption0.850.62 to 1.170.370.720.44 to 1.200.131.020.71 to 1.450.920.780.52 to 1.150.17
Phone/in-person interview1.050.86 to 1.270.631.090.92 to 1.300.351.140.94 to 1.390.150.860.68 to 1.090.16
Gene editing0.850.62 to 1.170.360.790.53 to 1.180.200.870.63 to 1.210.420.920.65 to 1.290.61
Allogenic transplants0.830.64 to 1.080.240.940.68 to 1.310.710.940.69 to 1.270.680.880.63 to 1.220.41
Latency reversing agents1.200.77 to 1.870.381.000.67 to 1.491.001.250.85 to 1.840.250.970.63 to 1.490.89
  • Bolded values represent statistically significant findings (p < 0.05).